(ADAG) Adagene - Performance -30.4% in 12m
ADAG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-77.09%
#122 in Peer-Group
Rel. Strength
16.27%
#6436 in Stock-Universe
Total Return 12m
-30.40%
#99 in Peer-Group
Total Return 5y
-93.66%
#141 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.49 USD |
| 52 Week Low | 1.39 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 57.20 |
| Buy/Sell Signal +-5 | -2.18 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ADAG (-30.4%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ADAG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADAG
| Total Return (including Dividends) | ADAG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.55% | 5.89% | 3.54% |
| 3 Months | 18.75% | 15.34% | 16.07% |
| 12 Months | -30.40% | -11.61% | 12.18% |
| 5 Years | -93.66% | -23.80% | 107.69% |
| Trend Score (consistency of price movement) | ADAG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -43.8% | 65.7% | 91.4% |
| 3 Months | 76.2% | 79.4% | 97.5% |
| 12 Months | -80.1% | -87.3% | 46.7% |
| 5 Years | -47.8% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th22.00 | -4.47% | -4.92% |
| 3 Month | %th53.00 | 5.79% | 2.31% |
| 12 Month | %th51.50 | -19.10% | -37.96% |
| 5 Years | %th40.00 | -87.35% | -96.27% |
FAQs
Does Adagene (ADAG) outperform the market?
No,
over the last 12 months ADAG made -30.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ADAG made 18.75%, while XBI made 15.34%.
Performance Comparison ADAG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ADAG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.2% | -5.1% | -2.6% | -43% |
| US NASDAQ 100 | QQQ | -0.3% | -5.9% | -5.1% | -43% |
| German DAX 40 | DAX | 0.1% | -3.5% | -15.7% | -60% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | -6.5% | -6.6% | -50% |
| Hongkong Hang Seng | HSI | -0.4% | -4% | -24.6% | -65% |
| India NIFTY 50 | INDA | 2% | -2.1% | -4% | -27% |
| Brasil Bovespa | EWZ | 4.9% | 1.4% | -14.7% | -31% |
ADAG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.5% | -4.4% | -9.7% | -55% |
| Consumer Discretionary | XLY | -1.2% | -5.6% | 2.2% | -48% |
| Consumer Staples | XLP | 2% | -1.8% | -4.1% | -38% |
| Energy | XLE | -1.7% | -2.7% | 4.8% | -30% |
| Financial | XLF | 0.8% | -5.9% | -6.7% | -54% |
| Health Care | XLV | 0% | -1.5% | 5.7% | -23% |
| Industrial | XLI | -0.9% | -7% | -10% | -53% |
| Materials | XLB | -0% | -5.4% | -3.6% | -33% |
| Real Estate | XLRE | -0.4% | -2.3% | -3.2% | -38% |
| Technology | XLK | 0.3% | -6.9% | -9.6% | -40% |
| Utilities | XLU | -0.4% | -4.4% | -7.9% | -53% |
| Aerospace & Defense | XAR | -2.5% | -11.5% | -25.5% | -80% |
| Biotech | XBI | -5.1% | -7.4% | 1.1% | -19% |
| Homebuilder | XHB | -2.3% | -10.9% | 5.2% | -27% |
| Retail | XRT | -0.6% | -6.7% | -1.7% | -38% |
ADAG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.7% | 2.23% | 10.4% | -25% |
| Natural Gas | UNG | -0.7% | 8.4% | 20.2% | -36% |
| Gold | GLD | -0.3% | 0.1% | -20.3% | -67% |
| Silver | SLV | -2.4% | -5.3% | -19.6% | -53% |
| Copper | CPER | -1.1% | -15.2% | -21.3% | -53% |
ADAG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.2% | -2.1% | 0.4% | -27% |
| iShares High Yield Corp. Bond | HYG | 0.7% | -2.4% | -0.6% | -39% |